Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges.Published in:Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-47By:Han, Ethan Q.;Xiu-ling Li;Chun-rong Wang;Tian-fang Li;Shuang-yin HanPublication type:Article